The number of people with susceptibility test result for rifampicin in Andorra
Andorra: The number of people with susceptibility test result for rifampicin was 2 in 2021. ▲ Rising
Latest (2021)
2
Change on year
up 100.0%
World rank
143rd
of 155 countries
All-time high
2
in 2019
All-time low
1
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Andorra, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Andorra stood at 2. That is the highest value across all 5 years on record.
That represents a change of up 100.0% on the previous year and up 100.0% over five years.
Andorra ranks 143rd of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Andorra, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1 | — |
| 2018 | 1 | +0.0% |
| 2019 | 2 | +100.0% |
| 2020 | 1 | -50.0% |
| 2021 | 2 | +100.0% |
Andorra compared with similar countries
- Andorra's 2 is below the median for high income countries, which is 142, 1% of the median. (61 countries reporting)
- Andorra's 2 is below the median for Europe & Central Asia, which is 229.5, 1% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.33 | 1 | 2 | 3 |
| 2020s | 1.5 | 1 | 2 | 2 |
Countries ranked near Andorra
- 140 Seychelles 9 compare
- 141 Tonga 7 compare
- 142 Palau 6 compare
- 143 Saint Lucia 2 compare
- 143 Bermuda 2 compare
- 146 Grenada 0 compare
- 146 Niue 0
- 146 Mauritania 0 compare
- 146 Barbados 0 compare
- 146 Saint Kitts and Nevis 0 compare
- 146 Sao Tome and Principe 0 compare
- 146 Vanuatu 0 compare
- 146 South Sudan 0 compare
- 146 Antigua and Barbuda 0
- 146 Saint Vincent and the Grenadines 0 compare
More health data for Andorra
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,824 deaths per 1,000 people (2090)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 09, male, interpolated 371 (2025)
- Population, male 42,360 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Andorra?
- The number of people with susceptibility test result for rifampicin in Andorra was 2 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Andorra?
- The highest recorded value was 2 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Andorra?
- The lowest recorded value was 1 in 2017.
- How does Andorra rank for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 143rd out of 155 countries with data for 2021.
- Where does this Andorra data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).